ABSTRACT
This textbook examines the most important aspects of multiple sclerosis that impact on clinical trial design, on the development of new disease therapies and on patient care. The international team of contributors discuss the clinical course of multiple sclerosis, its clinical heterogeneity, the presence of subclinical disease activity which occurs
TABLE OF CONTENTS
part I|2 pages
Introduction
part II|2 pages
Clinical trial methodology
part III|2 pages
Clinical trials of disease modifying therapy
part IV|2 pages
Disease modifying drug therapy in clinical practice
part V|2 pages
Symptomatic drug therapy in clinical practice